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Objectives. This study was designed to evaluate dobutamine
stress echocardiography in identifying reversible dysfunction and
assessing the extent of irreversibly damaged myocardium early in
acute myocardial Infarction .
nd. Several experimental and clinical studies have
s ted that dobutamine enhances contractile function of
stunned or hibernating, or both, myocardium
. It is important for
clinical strategy to predict the magnitude of improvement in
myocardial fUnctiot, early in acute myocardial Infarction
.
Methods. We studied 21 patients with a reperfused first ante-
rior myocardial infarction. Two-dimensional echocardiography
was performed before and during dobutamine infusion (10 pg/kg
body weight per min) at a mean of 3 days after the infarction .
Follow-up echocardiography was performed at a mean of 25 days
later. To assess segmental wall motion, we divided the left
ventricle into 17 segments and assigned a wall motion abnormal-
ity score: 3 = dyskinesia or akinesia; 0 = normal. Improvement in
wall motion was indicated by a decrease of at least one grade in
Coronary reperfusion, if achieved in the early stage of acute
myocardial infarction, may limit the progression of myocardial
necrosis and promote the functional recovery of postischemic
myocardium (1,2). Despite timely coronary reperfusion,
a
substantial amount of previously ischemic myocardium
may
result in prolonged contractile dysfunction (myocardial
stun-
ning) (3,4) . It
is difficult to differentiate stunned (or hibernat-
ing) myocardium from irreversibly damaged myocardium in
individual patients
. This distinction is important in determin-
ing therapeutic strategy and prognosis because the area of the
stunned myocardium is likely to recover its function, and
its
area is
a primary determinant of residual cardiac function
.
Positron emission tomography and thallium-201
imaging
have been used to identify myocardial viability in patients with
From the Division of Cardiology, Sakurabashi Watanabe Hospital, and
'First Department of Medicine, Osaka University School of Medicine, Osaka,
Japan.
Manuscript received December 10, 1993
; revised manuscript received April
18, 1994, accepted April 21, 1994
.
Address for correspondence
: Dr
. Hiroshi [to, Division of Cardiology,
Sakuraba
.shi Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka 530, Japan
.
C1994 by the American College of Cardiology
JACC Vol . 24, No . 3
September 1994 :624-30
MYOCARDIAL ISCHEMIA
segmental score. For quantitative assessment, the ratio of cndo-
cardial length showing dyskinesia or akinesia to a left ventricular
endocardial length (akinetic length ratio) was determined in the
apical long-axis view at each stage.
Results. Sensitivity and specificity of dobutamine infusion in
detecting improvement in wall motion at follow-up echocardiog-
raphy were 83% (55 of 66 segments) and 86% (43 of 50 segments),
respectively
. Excellent correlation was found (r = 0
.93, p
<
0.001
;
absolute difference [mean ± SD) 0 .03 ± 0.05) between the
akinetic length ratios measured during dobutamine infusion and
in the late convalescent stage
.
Conclusions. In the early stage of acute myocardial infarction,
low dose dobutamine stress echocardiography provides a useful
method for predicting reversible dysfunction with excellent sensi-
tivity and specificity and can also be used to quantitate the extent
of irreversibly damaged myocardium .
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ischemic heart disease (5-7) . Although these techniques, which
are based on the cellular uptake of tracers, might reflect
myocardial perfusion and metabolic activity, they do not
provide direct information with respect to contractile function
and require expensive nuclear medicine facilities . At the same
time, beta-adrenergic stimulation has been shown (8-11) to
elicit a contractile response in the area of reversible postisch-
emic dysfunction . Previous studies (12-14) have demonstrated
that dobutamine stress echocardiography is useful in identify-
ing hibernating myocardium and in predicting improvement in
wall motion after coronary revascularization in patients with
chronic ischemic heart disease. Other clinical studies have
suggested that improved wall motion during dobutamine infu-
sion may predict postischemic reversible dysfunction even in
the early convalescent stage (a mcan of 5 to 14 days) after
myocardial infarction (15-17) .
In this study, we performed dobutamine stress echocardi-
ography in the coronary intensive care unit as early as 3 days
after infarction in patients with reperfused anterior wall myo-
cardial infarction. We validated the feasibility of dobutamine
stress echocardiography in identifying reversible dysfunction of
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postischemic myocardium and in predicting the extent of
irreversibly damaged myocardium by comparing the findings
with an echocardiographic assessment of wall motion abnor-
malities in the late convalescent stage (a mean of 25 days) after
acute myocardial infarction,
Methods
Study patients. From June 1992 to May 1993, 26 patients
with reperfusion therapy for a first anterior wall acute myocar-
dial infarction underwent two-dimensional echocardiographic
studies on the day of infarction . The diagnosis of an anterior
acute myocardial infarction was made on the basis of chest
pain >30 min, ST segment elevation of at least 2 mm in two
continuous precordial electrocardiographic (ECG) leads, exis-
tence of anteroseptal asynergy evaluated by two-dimensional
echocardiography and a greater than threefold increase in
serum creatine kinase levels. Three patients were excluded
from the study because of inadequate image quality of echo-
cardiography at rest. The remaining 23 patients underwent
dobutamine stress echocardiography early after the onset of
the infarction. Two patients were excluded from data analysis
for the following reasons : high grade residual coronary stenosis
(Thrombolysis in Myocardial Infarction [TIMI] trial flow grade
1) in one patient and an ischemic event during follow up in the
other. Therefore, we studied 21 patients (18 men, 3 women ;
mean age 55 years, range 36 to 74) . All patients achieved
coronary reflow (TIMI flow grade 3, residual diameter stenosis
575%) by coronary angioplasty within 24 h of the onset of
infarction (mean 10 h) . The protocol was approved by the
hospital ethics committee, and informed consent was obtained
from each patient by one of the investigators .
Cardiac cathetcrizatinn . All patients underwent coronary
angiography using the Judkins technique immediately after
infarction and 4 weeks later (24 to 30 days) . Coronary artery
stenosis was evaluated quantitatively. A reduction ?75% in
lumen diameter present in at least one major epicardial vessel
was considered significant . The right anterior oblique view of
left ventriculograms obtained on the day of the infarction and
4 weeks later were used for assessment of global left ventric-
ular function. End-diastolic and end-systolic contours were
traced in the frames with maximal and minimal volumes,
respectively . Left ventricular volume was calculated by the
area-length method. Left ventricular ejection fraction was
calculated from these volumes .
Dobutamine stress echocardiography . This procedure was
performed in the cardiac intensive care unit at a mean of 3 days
(range 2 to 5) after the onset of myocardial infarction . No
patient had received an isotropic agent before the examina-
tion. Other medications, such as nitrates, angiotensin-
converting enzyme inhibitors, diuretic drugs and antiarrhyth-
mic agents, were not withdrawn . Ultrasound was performed
with a commercially available electrical sector scanner (model
SSH-65A, Toshiba, Tokyo, Japan) equipped with a 3 .75-MHz
transducer. The patient rested in the left lateral position and
breathed normally. Short-axis slices at the levels of the mitral
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valve and midpapillary muscle and the apical long-axis slice
were recorded on a VHS videocassette (model BR-6000,
Victor, Yokohama, Japan) in a baseline study . Heart rate and
systolic blood pressure were also measured . During continuous
ECG monitoring, an intravenous infusion of dobutamine
(5 µg/kg body weight per min [low dose]) was started with an
infusion pump and continued for 6 min . A two-dimensional
echocardiographic study was repeated at the end of the
dobutamine infusion. The dose of dobutamine was then in-
creased to 10 µg/kg per min (intermediate dose) for another
6 min, and the two-dimensional echocardiographic study was
repeated. Patients underwent continuous ECG monitoring,
and their blood pressure was recorded at 3-min intervals with
an automated cuff. The criteria for stopping dobutamine
infusion included hypotension, angina and significant ventric-
ular arrhythmias. Follow-up echocardiography was repeated at
a mean of 25 days (range 23 to 27) later, and all standard views
were recorded .
Analysis of echocardiography . Videotaped echocardio-
graphic images were digitized, and a quad screen format was
used to simultaneously compare rest images with stress images
in the same imaging planes . In each view the R wave was
triggered to capture a representative cardiac cycle at 30
frames/s . Thus, digitized stress images were analyzed by direct
comparison with baseline images . To perform the study in a
blinded manner, stress test and late follow-up images were
presented in a random sequence with baseline images.
The left ventricle was divided into 17 segments (eight
segments on each short-axis slice at the levels of the mitral
valve and midpapillary muscle and an apical segment on the
apical long-axis view) (Fig . 1) (18). The following scoring
system was used: 3 = dyskinetic or akinetic ; 2 = severely
hypokinetic; I = hypokinetic; 0 = normal . Hyperkinesia was
not given a score. In evaluating segmental wall motion abnor-
malities, we carefully examined systolic thickening in the
central portion of each segment. Segmental score was deter-
mined by two independent observers who were unaware of the
clinical data . In cases of disagreement, a consensus was
established with a third observer. Improved wall motion was
indicated by a decrease in score of at least one grade at any
gap of the dobutamine infusion compared with the baseline
study. Reversible dysfunction was defined as improved wall
motion (a reduction in segmental score of at least one grade)
at ate follow-up compared with the baseline study . The total
segmental score was determined at each stage for each patient .
Regional wall motion was quantitatively analyzed using an
apical long-axis view. Abnormal contraction was defined as
dyskinesia or akinesia, showing no inward endocardial motion
during systole, in this analysis (4). The endocardial length of
the end-diastolic segment showing abnormal contraction and
that of the entire left ventricle were digitized in each stage
using art image analyzing system (LA-500, PIAS, Osaka,
Japan) to determine the ratio of the endocardial length
showing the abnormal contraction to that of the entire left
ventricle (akinetic length ratio) (Fig
. 1). The akinetic length
ratios during 10 µg/kg per min of dobutamine infusion were
626
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Figure 1 . Seventeen-segment two-dimensional cchocardiographic
model (left) and schematic illustration of the measured segment length
showing abnormal contractile (akinetic segment length) and the entire
endocardiall length (right) . Abnormal contraction was defined as
akinesia or dyskinesia (Dys), showing no inward endocardial motion
during systole . The endocardial length of the end-diastolic segment
showing akinesia or d) ,skincsia (no inward motion) was measured in
each ultrasound study. To assess the extent of irreversible myocardial
damage relative to the entire left ventricle, we calculated the ratio of
the length of abnormal contractile segments to that of the total
endocardial length (akinetic length ratio) . MV = mitral valve ; PM
midpapillary muscle.
compared with those ratios determined at a mean of 25 days
after infarction to assess the accuracy of dobutamine stress
echocardiography in identifying the extent of irreversibly dam-
aged myocardium .
Reproducibility of data . To assess the reproducibility of
measuring the endocardial length, 20 echocardiographic im-
ages were randomly selected . Measurements of the endocar-
dial length of the akinetic or dyskinctic segment and the entire
left ventricle were determined by one observer on two occa-
sions (intraobserver variability) . Another observer indepen-
dently performed the determination for the same 20 images
(interobserver variability). The observers were unaware of the
patients' data or of each other's results . The mean (±SD)
absolute differences between observers were 3.0 ± 1.8%
(intraobserver) and 5.5 ± 3.8% (interobserver) for the endo-
cardial length of the akinetic or dyskinetic segment, and 2.0 ±
1 .81, (intraobserver) and 2.0 ± 2.0% (interobserver) for the
en - `il length of the entire left ventricle .
.___:_al analysis. Data are expressed as mean value
SD. Sensitivity and specificity were calculated with standard
formulas . The statistical significance :
rate, systolic blood pressure and values for akinetic length
ratios and total wall motion score were tested with analysis of
variance and the Sche& F test for repeated measures . Linear
regression analysis was used to evaluate the correlation be-
tween two measurements
. Differences were considered signif-
icant at p <
0.05.
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Results
Safety. Heart rate and systolic blood pressure increased
with dobutamine dose (heart rate [beats/min] at rest 81 ± 14,
at low dose dobutamine 86 ± 15 [p < 0 .01 vs . heart rate at rest]
and at intermediate dose dobutamine 97 ± 17 [p < 0 .01 vs .
heart rate at rest, p < 0.01 vs. low dose dobutaminc] ; blood
pressure [mm Hg' at rest 117 ± 12, at low dose dobutamine
124 ± 15 [p < 0.01 vs. blood pressure at rest] and at
intermediate dose dobutamine 128 ± 15 [p < 0.01 vs. blood
pressure at rest]) . Chest pain, shock or hemodynamic distur-
bances were not observed during dobutamine infusion . Spo-
radic ventricular arrhythmias were observed in one patient .
One patient reported palpitation, and four reported facial
flushing, but the intermediate dose was well tolerated in all
patients .
Patient characteristics . All patients had single-vessel dis-
ease (Table 1). Each patient achieved successful coronary
reperfusion with <50^% residual stenosis, and none exhibited
significant progression of stenosis at late follow-up . Seventeen
patients had 0 wave and four patients non-0 wave myocardial
infarction. Left ventriculography was performed in 19 patients
at day I and in all patients at late follow-up . Serial changes in
wall motion score were assessed in each patient, except for
Patient I whose short-axis images were poor . Medications
during follow-up included nitrates in 21 patients (I(X)%r),
calcium-channel blocking agents in 16 (76%), angiotensin-
converting enzyme inhibitors in six (29%), antiarrhythmic
drugs in six (29%) and diuretic agent` in two (9%) . Beta-
blockers were not used in any patient .
Wall motion during dobutamine stress test . Patients with
improved anteroseptal and lateral wall motion during the
intermediate dose (10 ttglkg per min) of dobutamine showed
recovery of contractile function in these segments at late fol-
low-up (Fig. 2) . In contrast, patients with little improvement in
anteroseptal and lateral wall motion during the intermediate dose
of dobutamine showed akinesiaa in these segments at late fol-
low-up (Fig. 3) .
We successfully evaluated segmental wall motion in 341
(96%) of 357 segments with adequate image quality . Abnormal
wall motion (segmental score a-1) was observed in 116 seg-
ments at baseline study, 44 (38%) of which showed improved
segmental motion at low dose dobutamine stress . An improve-
ment in segmental motion was observed in 40 of these 44
segments at late follow-up (positive predictive value 91%). By
contrast, improvement in segmental wall motion was not
observed at late follow-up in 47 of 72 segments that showed no
improvement during low dose dobutamine stress (negative
predictive value 65%). Thus, sensitivity and specificity for
predicting improved segmental wall motion with low dose
dobutamine stress echocardiography were 62% and 92%,
respectively.
With intermediate dose (10 ItAg per min) dobutamine
stress, functional improvement was observed in 62 (53%) of
116 segments showing asynergy at baseline study, of which 55
had improved contractile functlim at late follow-up (positive
Pt Age (yr), Involved Culprit Pic-PTCA Pest-CT CA Chronic Type of Peak C'K Acute
Chronic
	
Lite Late
No, (lender Vessels t .cston' (TIMI) (!Y') (`-;) Infarction (IU,liter)
(el.) (%) Baseline Dub Follow-Up Baseline Dob Follow-Up
"6 = preseptal : 7 = postseptal . Wall mwion score (WMS) could not he determined because of poor short-axis i mage. CK = creatine kinase ; Dub = intermediate
dose of dotsutamine ; F == female; M = male : ND = not determined ; Pt
..
patient : PTCA = percutancous transluminal coronary angioplasty :
Q(NQ) - Q(non-Q) wave
infarction: TIM( = Thrombolysis in Myocardial Infarction trial (low grade .
predictive value 89%) . Conversely, 43 of 54 segments that did
not exhibit improvement with intermediate dose stress failed to
recover contractile function at late follow-up (negative predic-
tive value 80%) . Thus, sensitivity and specificity for predicting
improved segmental motion with intermediate dose dobut-
amine stress echocardiography were 83% and 86%, respec-
tively . Although the specificity was almost identical (92%
Baseline
Figure 2 . End-diastolic (ED) and
end-systolic (ES) stop-frame im-
ages of illustrative echocardio-
grams obtained in a patient with
acute anterior myocardial infarc-
tion . Parasternal short-axis views
are shown . Akinesia of the antero-
septal and anterior segments is
present at rest (arrows) ; systolic
myocardial thickening becomes aF-
parent with dobutamine (Dob) . At
late follow-up, the affected seg-
ments are akinetic (arrows) . The
extent of akinesia at late follow-up
is similar to that observed during
the intermediate dose of dobut-
amine .
ED
ES
low, 86%% = intermediate), the sensitivity was better for
intermediate than for low dose dohutamine stress echocardi-
ography (62% = low, 83% = intermediate) .
Total wall motion score was 14 ± 7 at baseline, 10 ± 7
during the intermediate dose dohutamine stress (p < 0 .01 vs .
baseline) and 9 ± 7 at late follow-up (p < 0 .01 vs. baseline) .
Total wall motion score significantly decreased at intermediate
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Table 1 . Clinical Characteristics of 21 Study Patients
Ejection
No. of
Stenosis
Fraction Total WMS
Akinetic Length Ratio
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ED
dose dobutamine stress and correlated well with that observed
at late follow-up (r = 0.94, p < 0 .01).
Identification of extent of irreversibly damaged myocar-
dium. Akinetic length ratio values were compared at baseline,
during intermediate dose dobutamine stress and it late
follow-up (Fig. 4). Similar to wall motion score, the akinetic
length ratio significantly decreased at intermediate dose do-
butamine stress and correlated well with that observed at late
follow-up (r = 0.93, p < 0.(X)1, absolute difference 0.03 ± 0 .05)
(Fig . 5) . The regression line was close to that of identity . These
findings indicate that the akinetic length ratio obtained at
intermediate dose dobutamine stress may he used to predict
that at late follow-up .
There was a significant correlation between akinetie length
ratio and total wall motion score (r = 0.89, p < 0.001) and
Figure 4. Plots of akinetic length ratios in all 21 patients at baseline,
during the intermediate dose of dobutamine and at late follow-up .
There was a significant reduction in the values for akinetic length ratios
during the intermediate dose of dobutamine and at late follow-up
compared with baseline values . Mear, values t SD are shown .
Akinetic length ratio
p4.01
Baseline
Deb
_ 10
'min-' Late stage
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Figure 3. End-diastolic (ED) and
end-systolic (ES) stop-frame im-
ages of illustrative echocardio-
grams obtained in a patient with
acute anterior myocardial infarc-
tion, This patient showed a poor
response to dobutamine (Dob)
compared with the patient in Fig-
ure 2. Parasternal short-axis views
are shown . Akinesia of the antero-
septal and lateral segments is
present at baseline (arrows) ; no
significant improvement was ob-
served with intermediate dose of
dobutamine . At late follow-up, the
broadly affected segments are aki-
netic .
between akinetic length ratio and ejection fraction (r = -0 .86,
p < 0.01) at late follow-up. These findings indicate that the
akinetic length ratio reflects both the extent of abnormal wall
motion and the severity of left ventricular dysfunction .
Discussion
Comparison with previous studies . Because experimental
studies (9-11) have demonstrated that postischemic ventricu-
lar dysfunction can be reversed with intravenous infusion of
catecholamines, the potential of dobutamine stress echocardi-
ography for identifying reversible postischemic dysfunction
after myocardial infarction has been investigated in clinical
studies . Pierard et al. (15) performed dobutamine stress echo-
cardiography at a mean of 7 days after thrombolysis and
Figure 5. Values for akinetic length ratios during the intermediate
dose of dobutamine compared with those at late follow-up . There is an
excellent correlation between the two variables . The regression line is
close to the line of identity, indicating that these two variables
correlate well with each other .
Akinetic length ratio
(late stage)
y=1 .12x-0.23
n
0 0.5
Akinetic length ratio (Dobutamine 10pg kg-'min-')
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compared their findings with those from glucose uptake and
perfusion assessment by positron emission tomography . They
concluded that identification of noncontractile but viable myo-
cardium with dohutamine stress echocardiography is similar to
that by positron emission tomography . Satler et al . (14) found
significantly greater improvement in wall motion in patients
with a patent infarct-related artery than in those with persis-
tent occlusion during dohutamine infusion . However, they
assessed patency at predischarge catheterization and did not
evaluate long-term functional recovery . Barilla et al . (16)
investigated the sensitivity of low dose dobutamine stress
echocardiography for predicting the magnitude of improve-
ment in patients with anterior wall myocardial infarction. They
demonstrated that dobutamine-responsive wall motion assess-
merit using a scoring system may be sensitive for the determi-
nation of reversible postischemic dysfunction after coronary
revascularization . The study group, however, was restricted to
those with small infarcts because 16 of 21 enrolled patients had
non-0 wave infaretic ii, and the specificity of dobutamine stress
echocardiography was not assessed. In addition, the majority of
the study patients had critical coronary artery stenosis during
the dobutamine stress test .
In a recent study, Smart et al . (17) performed multistage
dobutamine stress echocardiography within 7 days of throm-
bolytic therapy. They noted that patients who had improved
segmental left ventricular function with low dose dobutamine
infusion had long-term improvement as well, whereas those
who did not improve at low and peak doses (20 to 40 tLg/kg per
min) did not have functional recovery at follow-up . However, it
was unknown whether the infarct-related artery was patent
during dobutamine infusion. Occlusion and critical residual
stenosis of the infarct-related artery remained in 18% and 76%
of study patients, respectively . The influence of this residual
coronary artery stetiosis or occlusion might not be negligible .
Present study. We performed two-stage dobutarnine stress
echocardiography as early as 3 days after the onset of myocar-
dial infarction . All patients undenvent coronary angioplasty,
and residual stenosis was <50% . Our patients had substant'al
wall motion improvement within the risk area during dobut-
aminc infusion. Wall motion response to the intermediate dose
of dohutamine was highly sensitive and specific for predicting
the functional recovery of segmental contraction seen at late
follow-up echocardiography . This observation is in agreement
with previous results (15-17) .
Extent of irreversibly damaged myocardium . Knowledge
of the extent of irreversibly damaged myocardium in the acute
stage of infarction will determine clinical decisions because a
large infarction may lead to congestive heart failure and
progressive dilation of the left ventricle (19,20) . Such patients
may need aggressive forms of load-reduction therapy . In our
previous study (4), the time course of functional recovery of
the involved myocardium within the risk area was determined
with myocardial contrast echocardiography to show that the
length of the segments showing abnormal contraction reduced
by a mean of 16% at 3 days after the infarction and by 28% 28
days later (4) . Therefore, we could not determine the full
WATADA El AL
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extent of wall motion recovery at 3 days after infarction by
echocardiography at test .
In this study, we examined whether an intermediate dose of
dobutamine could predict the extent of severely damaged
myocardium
. We measured the endocardial length of the
segments showing abnormal contraction during intermediate
dose dobutamine stress compared with that at late follow-up
echocardiography
. Our data demonstrated that the extent of
abnormal contraction during intermediate dose stress corre-
lated well with that at late follow-up echocardiography. There-
fore, in addition to evaluating the reversibility of the dysfunc-
tional segments, we could predict the extent of the irreversibly
damaged myocardium with intermediate dose dobutamine
stress echocardiography in acute myocardial infarction .
Dobulamine dose. The optimal dose of dobutam ine for
detection of postischemic reversible dysfunction is not fully
elucidated . Several clinical studies have demonstrated the
utility of an intermediate dose (10 ILg/kg per win) in assessing
myocardial viability in the early convalescent stage . Smart et al .
(17) demonstrated that the low dose (4 jig/kg per min) was
more sensitive and specific than the intermediate dose in the
detection of reversible dysfunction in the early stage of acute
myocardial infarction . They pointed out the possibility that
hemodynamic alterations produced by higher doses of dobut-
amine may cause a dose-related decrease in sensitivity. In our
study, the intermediate dose was more sensitive than the low
dose in detecting reversible dysfunction (83% vs . 62%), The
sensitivity of the intermediate dose was similar to that of the
low dose (86 vs . 92%). The reason for the difference between
the Smart et al . study and ours with respect to the optimal dose
of dobutamine is unclear. Because the majority of their study
patients had critical coronary stenosis, myocardial ischemia
may have been introduced by high dose dobutamine stress,
which may account for the relatively low sensitivity of high
dose dobutaniine stress echocardiography in the detection of
reversible dysfunction. We did not attempt maximal dose
dobutamine stress because we were concerned about possible
cardiac rupture caused by an unusually hyperdynamic state .
Therefore, we conclude that intermediate dose dobutamine
stress echocardiography is more sensitive and specific for
detecting reversible dysfunction than low dose dobutamine
stress echocardiography. a t least in patients without critical
residual coronary stenosis .
The functional changes in the border zone of the infarct-
related area may be of concerti . Ischernic myocardium may
influence the function of the adjacent normal tissue . Recent
experimental and clinical studies (21,22) indicate that dysfunc-
tion extends 1 cm outside the ischernic area . Dobutamine
increases myocardial thickening of the nonischemic myocar-
dium adjacent to the necrotic tissue,
producing a decrease in
the size of the functional border zone . In our study, a signifi-
cant contractile improvement was observed in the central
ischemic area ; however, a few segments in the functional
border zone also responded to dobutamine stress . Thus, the
extent of abnormal wall motion in the late convalescent stage
may be predicted by dobutamine stress echocardiography in
JACC Vol . 24, No . 3
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the early stage of acute infarction, irrespective of the etiology
of the reversible dysfunction (i.e .,
either in the ischemic area or
in the functional border zone).
Study limitations. Measurement of endocardial segmental
length can be influenced by the quality and setting of the
echocardiographic plane. In our series of echocardiographic
examinations, we tried to depict the same plane as in the initial
recording as much as possible by referring to the initial
echocardiographic images. Changes in left ventricular mor-
phology during the clinical course, such as expansion or
aneurysm, may well have influenced the measurements of the
endocardial length of the abnormal contractile segment as well
as that of the left ventricle, However, no patients showed a
significant infarct-related expansion during the follow-up pe-
riod, prohab y because early reperfusion was successfully
achieved in alt.
Regional dysfunction was assessed in a semiquantitative fash-
ion by the analysis not only of wall motion, but also of regional
wall thickening for the following reasons, First, wall-motion
abnormality is an obviously imperfect measure of regional dys-
function. Second, qualitative analysis incorporating an estimation
of both wall thickening and wall motion remains the current
standard . Third, wall thickening is not influenced by cardiac
translation and rotation. Fourth, images were analyzed in blinded
manner; therefore, it is unlikely that the results would have been
biased by the application of a quantitative method.
Shrinkage of the infarct scar may contribute to a decrease in
the abnormal contractile segment at the late convalescent
stage. However, it is difficult to quantitate the amount of the
shrinkage in patients. We determined the extent of irreversibly
damaged myocardium at 1-month follow-up . Hibernation,
however, cannot be absolutely excluded as a cause of contin-
ued wall motion abnormalities, even with less severe coronary
artery stenosis,
Clinical implications. Our results demonstrated the use of
dobutamine stress echocardiography in the evaluation of pa-
tients with reperfused acute myocardial infarction to predict
functional' recovery and the extent of myocardial infarction .
Patients with poor functional recovery during dobutamine
infusion may show left ventricular dilation even with coronary
reflow . Dobutamine stress echocardiography is inexpensive
and highly portable; thus, studies can be performed in intensive
and coronary care units . It may also provide useful information
about the prediction of functional recovery in patients with
heart failure after acute myocardial infarction,
We acknowledge the skillful technical assistance of Yuzo Sakagami and
Masakazu Ueda and the excellent secretarial assistance of Rie Nishizawa
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